Non-pharmacological treatment of hypertension in primary health care: A comparative clinical trial of two education strategies in health and nutrition

Table 5 Anthropometric, clinical and biochemical variables in both groups of hypertensive women before and after intervention; Porto Firme, MG, Brazil, 2009.

	Group 1 (workshops)				Group 2 (workshops + home orientation)
	Initial (T0)	Final (T3)	Z	p^a	Initial (T0)	Final (T3)	Z	p^a
Weight, kg	75.3 ± 17.4	75.4 ± 16.3	-0.126	0.452	77.7 ± 14.2	76 ± 13.1	-2.098	0.018*
BMI, kg/m ²	31.3 ± 7	31.3 ± 6.3	-0.157	0.440	33.4 ± 5.7	32.7 ± 5.3	-2.062	0.019*
WC, cm	100.3 ± 14.9	98.5 ± 14.5	-2.100	0.017*	104 ± 12.2	99.7 ± 11.5	-2.986	0.001*
Systolic BP, mmHg	119.3 ± 14.9	117.4 ± 15.9	-0.637	0.261	129.3 ± 17	116.1 ± 9.6	-2.631	0.004*
Diastolic BP, mmHg	80.7 ± 10.7	77.1 ± 14.9	-0.962	0.168	78.4 ± 10.7	76.9 ± 7.5	-0.486	0.344
Glucose, mg/dL	110.9 ± 67.3	85.8 ± 14.6	-1.083	0.279	116.8 ± 35	97.8 ± 27.8	-2.552	0.011*
Triglycerides, mg/dL	172.1 ± 84.3	146.7 ± 71	-0.464	0.650	147.3 ± 72.8	131.3 ± 51.5	-0.804	0.421
Cholesterol total, mg/dL	220.8 ± 54.1	212.3 ± 52.8	-0.035	0.972	203.5 ± 56.2	193.3 ± 30.1	-0.393	0.695
LDL-cholesterol, mg/dL	136 ± 30.6	136.3 ± 42.9	-0.175	0.861	123.5 ± 48.6	117.4 ± 24.8	-0.175	0.861
HDL-cholesterol, mg/dL	42.2 ± 6.2	46.5 ± 13	0.877	0.381	50.9 ± 8.8	49.5 ± 9.3	-0.350	0.727

Values in cells are mean ± standard deviation; ^a p-value for difference in values before and after intervention in Groups 1 and 2 by the Wilcoxon test; *p < 0.05.

ISSN: 1471-2458